MAGIC-MT study is multi-center, prospective, randomized (1:1) controlled trial designed to show that additional MMA embolization with Onyx in patients with non-acute symptomatic subdural hematoma(SDH) results in reduced hematoma recurrence in surgically treated patients/ reduced hematoma progression in conservatively managed patients.
MAGIC-MT is a clinical study jointly sponsored by Huashan Hospital affiliated to Fudan University and Shanghai Changhai Hospital , and has completed registration by Clinical Trials（ClinicalTrials.gov Identifier: NCT04700345）.
The upper menu helps you to navigate through this website and access more information about this trial.
Kind regards
On behalf of the MAGIC-MT steering committee
MAGIC-MT principle investigators